FIELD: medicine. SUBSTANCE: method involves inactivating ciliary body by administering 0.5% etoxisclerol sclerosing preparation as injection into Tenon's capsule and sclera 2 mm aside from the limb in parallel to the limb through conjunctiva at a dose of 0.1-0.05 ml. EFFECT: reduced risk of traumatic complications.
Authors
Dates
2001-04-20—Published
1998-07-02—Filed